Clinical and Experimental Immunology

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.  210:91-103. 2022

Plasma levels of soluble membrane attack complex are elevated despite viral suppression in HIV patients with poor immune reconstitution.  198:359-366. 2019

Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.  174:414-423. 2013

Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia.  170:321-332. 2012

Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.  145:277-286. 2006

Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults.  144:117-124. 2006

Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.  142:548-554. 2005

Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.  135:497-504. 2004

Natural materno-fetal transfer of antibodies to PspA and to PsaA.  135:474-477. 2004

High prevalence of complement component C6 deficiency among African- Americans in the South-eastern USA.  119:305-310. 2000

Molecular defects leading to human complement component C6 deficiency in an African-American family.  111:91-96. 1998

Mercury-induced renal immune complex deposits in young (NZB x NZW)F1 mice: characterization of antibodies/autoantibodies.  110:86-91. 1997

Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID).  108:477-483. 1997

Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels.  109:356-361. 1997

T cell receptor (TCR) BV gene repertoires and clonal expansions of CD4 cells in patients with HIV infections.  107:21-30. 1997

Thiol compounds inhibit mercury-induced immunological and immunopathological alterations in susceptible mice..  107:68-75. 1997

Selected Th1 and Th2 cytokine mRNA expression by CD4⁺ T cells isolated from inflamed human gingival tissues.  103:422-428. 1996

Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation.  104:538-542. 1996

Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.  96:356-363. 1994

Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.  92:152-157. 1993

Genital secretory immune response to chronic simian immunodeficiency virus (SIV) infection: A comparison between intravenously and genitally inoculated Rhesus macaques.  88:520-526. 1992

IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy.  89:315-320. 1992

Molecular heterogeneity of human IgA antibodies during an immune response.  87:1-6. 1992

Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue.  85:341-348. 1991

Human rib bone marrow mononuclear cells spontaneously synthesize and secrete IgE in vitro.  83:163-168. 1991

Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells.  81:142-148. 1990

Bacteroides-specific IgG and IgA subclass antibody-secreting cells isolated from chronically inflamed gingival tissues.  76:103-110. 1989

IgA subclasses of human colostral antibodies specific for microbial and food antigens.  78:85-90. 1989

Features of renal vasculitis in autoimmune MRL 1pr/1pr mice: Phenotypes and functional properties of infiltrating cells.  72:91-97. 1988

Deleterious effect of ultraviolet-B radiation on accessory function of human blood adherent mononuclear cells.  70:116-126. 1987

Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: Differences between ulcerative colitis, Crohn's disease, and controls.  66:209-215. 1986

Relationship between immune system and gram-negative bacteria. III. Functional analysis of human peripheral blood lymphocyte subpopulations separated by cytoadherence with Salmonella minnesota Rb.  62:248-255. 1985

Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes.  51:261-268. 1983

A search for an enriched source of polymeric IgA in human thoracic duct lymph, portal vein blood and aortic blood.  48:85-90. 1982

Insulin-specific antibodies and insulitis in mice immunized with purified porcine insulin.  47:77-84. 1982

Inhibition of the pokeweed mitogen-induced response of normal peripheral blood lymphocytes by humoral components of colostrum.  45:386-392. 1981

Presence of J chain in human lymphoid cells.  39:371-385. 1980

Human colostral cells. I. Separation and characterization.  38:585-597. 1979

A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.  37:448-451. 1979

Monoclonal IgG3 kappa and IgG1 λ proteins with different iodiotypic determinants present in a single patient.  29:67-74. 1977

Presence of antibodies specific to cartilage type collagen in rheumatoid synovial tissue.  22:453-456. 1975

Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution..  9:733-748. 1971